Working with world class entrepreneurs.

We’ve raised over £65m for companies in tech and healthcare.

Epiphany Capital

Epiphany Capital is run by Tim Dempsey, an experienced dealmaker who has advised on over 35 transactions at Seed, Series A and growth stages, investing in each of these himself.

Tim is an advisor to several companies including PushDoctor, GSK, the University of Manchester and Campus Capital and co-founder of AlefBeisCode (coding school) and PowerOLEDs (hi-tech startup).

Working with world-class entrepreneurs, we’ve raised over £65m for companies in tech & healthcare

DATECLIENTTRANSACTIONSECTORTECHNOLOGY
2018SuperCarersSeries A RoundTechnologyHome Care Marketplace
2017E FundamentalsGrowth RoundTechnologyDeep Analytics for Brands
2017OTTYSeries A RoundEcommerceOnline Sleep Retailer
2018DNAFitPre-AcquisitionHealthtechConsumer DNA Testing
2017MIOTIFYSeed RoundTechnologyMedical IOT Regtech Platform
2017OTTYSeed Plus RoundEcommerceOnline Sleep Retailer
2017Push DoctorSeries B RoundHealthtechOnline Health Service
2017ThrivaSeed RoundHealthtechBlood Test as a Service
2017AthletecSeed RoundTechnologySports IoT
2017MotorwayBuddyMBOTechnologySaaS for Haulage
2016DwellSeed RoundTechnologyOnline Mortgages
2016DueCourseSeed RoundTechnologyOnline Invoice Finance
2016InstrumentelGrowth RoundTechnologyIoT/Advanced Manufacturing
2015PushDoctorSeries ATechnologyOn-Demand GP Platform
2015SuperCarersSeed RoundTechnologyHome Care Marketplace
2015FaceshiftAdvisory (Pre-Acquisition)Technology3D Facial Recognition
2015Digital BridgeSeed ExtensionTechnologyRetail Imaging
2014PropertyMooseVenture RoundTechnologyCrowdfunding Platform
2014PushDRVenture RoundTechnologyOn-Demand GP Platform
2014NerudiaStrategic RoundLife SciencesHigh Purity Nicotine
2014BrainomixVenture RoundLife SciencesDigital Stroke Diagnosis
2014BionurePre-clinical roundLife SciencesDrug development
2014Digital BridgeSeed RoundTechnologyAugmented reality
2014VideregenSeries A: £1.3mLife SciencesRegenerative medicine
2013GlycomarSeries A: £1mLife SciencesInflammation therapeutics
2013Power OLEDsFounding RoundTechnologyOLED materials development
2013PlayJamSeries A ExtensionTechnologyConnected TV gaming
2013MotorwayBuddySeed RoundTechnologyMobile payments for haulage
2013IncantheraSeries ALife SciencesCancer therapeutics
2013Cerus EndovascularSeries A: £2mLife SciencesNeurological medical devices
2012MolplexSeed RoundLife SciencesComputational drug discovery
2012Cable SenseSeries A: £850kTechnologyServer efficiency solution
2012CN CreativeGrowth Round: £2mLife SciencesNicotine replacement
2011IncantheraSeed RoundLife SciencesCancer therapeutics

Featured Companies